Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 615568-96-2 | MDL No. : | MFCD18807799 |
Formula : | C8H5FN2O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | N/A |
M.W : | 164.14 g/mol | Pubchem ID : | - |
Synonyms : |
|
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P301+P312-P302+P352-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: 4-fluoro-1H-benzimidazole-2-carbaldehyde; (1R)-1-[(4-amino-1-piperidinyl)methyl]-1,2-dihydro-4H,9H-imidazo[1,2,3-ij]-1,8-naphthyridine-4,9-dione dihydrochloride With sodium hydrogencarbonate; sodium sulfate In methanol; dichloromethane at 20℃; for 15h; Stage #2: With sodium tris(acetoxy)borohydride In methanol; dichloromethane at 25℃; for 4h; | 46 Example 46; (lR)-l-[(4-[(4-Fluoro-lH-benzimidazol-2-yl)methyl]amino}-l- piperidinyl)methyl] - 1 ,2-dihydro-4H,9H-imidazo [ 1 ,2,3-//] -1 ,8-naphthyridine-4,9- dione dihydrochloride; To a 10 mL round-bottomed flask were added (li?)-l-[(4-amino-l- piperidinyl)methyl]-l,2-dihydro-4η,9η-imidazo[l,2,3-ij]-l,8-naphthyridine-4,9-dione (for a preparation see Example 5A(j)) (80 mg, 0.238 mmol), 4-fluoro-lH-benzimidazole- 2-carbaldehyde (for a synthesis see WO2003087098, Example 320) (42.9 mg, 0.261 mmol), and sodium bicarbonate (100 mg, 1.190 mmol) in DCM (4 ml) and methanol (1 ml) to give a brown suspension. Sodium sulfate (200 mg, 1.408 mmol) was added and the reaction was stirred at rt overnight. After 15h sodium triacetoxyborohydride (101 mg, 0.475 mmol) was added and the reaction was stirred at 25 0C under nitrogen for 4h. The reaction mixture was adsorbed onto silica and purified using 0 - 10% MeOH/DCM (1% NH4OH) to give the free base of the title compound. The LCMS and IH NMR were consistent with the desired product.1H NMR δH D-4 MeOH, (400MHz) 1.35-1.55 (m, 2H), 1.90- 1.96 (m, 2H), 2.30-2.41 (m, 2H), 2.71-2.81 (m, 2H), 2.91-2.99 (m,lH), 3.05-3.15 (m, 2H), 4.20 (s, 2H), 4.41-4.50 (m, 2H), 4.69 (s, 2H), 5.10-5.20 (m, IH), 6.25-6.36 (m, 2H), 6.91- 7.05 (m, IH), 7.16-7.25 (m, IH), 7.31-7.39 (m, IH), 7.75-7.81 (m, 2H), MS (ES+) m/z 449 (MH+). The free base of the title compound was taken up in 10% MeOH/DCM and treated with IN HCl to form the title compound as the diHCl salt (17 mg, 0.033 mmol, 13.73 % yield) . |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1.1: sodium hydrogencarbonate; sodium sulfate / methanol; dichloromethane / 15 h / 20 °C 1.2: 4 h / 25 °C 2.1: hydrogenchloride / methanol; dichloromethane; water |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: 4-fluoro-1H-benzimidazole-2-carbaldehyde; (1R)-1-[(4-amino-1-piperidinyl)methyl]-1,2-dihydro-4H,9H-imidazo[1,2,3-ij]-1,8-naphthyridine-4,9-dione With sodium hydrogencarbonate; sodium sulfate In methanol; dichloromethane at 20℃; for 15h; Stage #2: With methanol; sodium tris(acetoxy)borohydride In dichloromethane at 25℃; for 4h; Inert atmosphere; | 46 Example 46 (1R)-1-[(4-[(4-Fluoro-1H-benzimidazol-2-yl)methyl]amino}-1-piperidinyl)methyl]-1,2-dihydro-4H,9H-imidazo[1,2,3-ij]-1,8-naphthyridine-4,9-dione dihydrochloride To a 10 mL round-bottomed flask were added (1R)-1-[(4-amino-1-piperidinyl)methyl]-1,2-dihydro-4H,9H-imidazo[1,2,3-ij]-1,8-naphthyridine-4,9-dione (for a preparation see Example 5A(j)) (80 mg, 0.238 mmol), 4-fluoro-1H-benzimidazole-2-carbaldehyde (for a synthesis see WO2003087098, Example 320) (42.9 mg, 0.261 mmol), and sodium bicarbonate (100 mg, 1.190 mmol) in DCM (4 ml) and methanol (1 ml) to give a brown suspension. Sodium sulfate (200 mg, 1.408 mmol) was added and the reaction was stirred at rt overnight. After 15 h sodium triacetoxyborohydride (101 mg, 0.475 mmol) was added and the reaction was stirred at 25° C. under nitrogen for 4 h. The reaction mixture was adsorbed onto silica and purified using 0-10% MeOH/DCM (1% NH4OH) to give the free base of the title compound. The LCMS and 1H NMR were consistent with the desired product. 1H NMR δH D-4 MeOH, (400 MHz) 1.35-1.55 (m, 2H), 1.90-1.96 (m, 2H), 2.30-2.41 (m, 2H), 2.71-2.81 (m, 2H), 2.91-2.99 (m, 1H), 3.05-3.15 (m, 2H), 4.20 (s, 2H), 4.41-4.50 (m, 2H), 4.69 (s, 2H), 5.10-5.20 (m, 1H), 6.25-6.36 (m, 2H), 6.91-7.05 (m, 1H), 7.16-7.25 (m, 1H), 7.31-7.39 (m, 1H), 7.75-7.81 (m, 2H), MS (ES+) m/z 449 (MH+). |
[ 885280-34-2 ]
6-Fluoro-1H-benzo[d]imidazole-2-carbaldehyde
Similarity: 0.91
[ 18645-89-1 ]
4-Fluoro-2-methyl-1H-benzo[d]imidazole
Similarity: 0.89
[ 1263379-05-0 ]
5,6-Difluoro-1H-benzo[d]imidazole-2-carbaldehyde
Similarity: 0.88
[ 874814-18-3 ]
4,6-Difluoro-2-methyl-1H-benzo[d]imidazole
Similarity: 0.88
[ 229957-09-9 ]
4,5-Difluoro-2-methyl-1H-benzo[d]imidazole
Similarity: 0.86
[ 885280-34-2 ]
6-Fluoro-1H-benzo[d]imidazole-2-carbaldehyde
Similarity: 0.91
[ 1263379-05-0 ]
5,6-Difluoro-1H-benzo[d]imidazole-2-carbaldehyde
Similarity: 0.88
[ 885280-34-2 ]
6-Fluoro-1H-benzo[d]imidazole-2-carbaldehyde
Similarity: 0.91
[ 18645-89-1 ]
4-Fluoro-2-methyl-1H-benzo[d]imidazole
Similarity: 0.89
[ 1263379-05-0 ]
5,6-Difluoro-1H-benzo[d]imidazole-2-carbaldehyde
Similarity: 0.88
[ 874814-18-3 ]
4,6-Difluoro-2-methyl-1H-benzo[d]imidazole
Similarity: 0.88
[ 229957-09-9 ]
4,5-Difluoro-2-methyl-1H-benzo[d]imidazole
Similarity: 0.86